Poder, disputas e geopolítica no setor farmacêutico
DOI:
https://doi.org/10.22481/rg.v8.e2024.e14550Palavras-chave:
Indústria Farmacêutica, Influência, Economia, Embates, PolíticaResumo
O setor farmacêutico atingiu receitas globais de US$ 1,6 trilhão em 2023, evidenciando seu vasto poder econômico e sua influência estratégica na economia e política contemporâneas. Este artigo, baseado em uma ampla coleta, sistematização e análise de dados, examina as dinâmicas desse poder e influência. São discutidos o valor econômico (e político) das empresas do setor, as disputas entre corporações e nações atuantes, o papel geopolítico desempenhado durante a pandemia de covid-19 e a capacidade do setor de influenciar políticas internas por meio da intensa interação e financiamento de legisladores, bem como de órgãos de fiscalização e regulamentação.
Downloads
Metrics
Referências
ABRAHAM, John. The pharmaceutical industry as a political player. The Lancet, [S.L.], v. 360, n. 9344, p. 1498-1502, nov. 2002. http://dx.doi.org/10.1016/s0140-6736(02)11477-2.
ACS - American Chemical Society. Emergence of Pharmaceutical Science and Industry: 1870-1930. Chemical & Engineering News. Washington, Estados Unidos, p. 1. 20 jun. 2005. Disponível em: https://cen.acs.org/articles/83/i25/EMERGENCE-PHARMACEUTICAL-SCIENCE-INDUSTRY-1870.html. Acesso em: 22 fev. 2024.
AKHTAR, Gulshan. Indian Pharmaceutical Industry: an overview. Iosr Journal of Humanities and Social Science, [S.L.], v. 13, n. 3, p. 51-66, 2013. http://dx.doi.org/10.9790/0837-1335166.
APOLINÁRIO-JÚNIOR, Laerte et al. Chinese and Indian COVID-19 Vaccine Diplomacy during the Health Emergency Crisis. Revista Brasileira de Política Internacional, [S.L.], v. 65, n. 1, p. 1-24, 2022. http://dx.doi.org/10.1590/0034-7329202200114.
BHARTI, Simant Shankar; BHARTI, Sushant Shankar. India’s Vaccine Diplomacy: role in new order and challenges. Torun International Studies, [S.L.], v. 1, n. 14, p. 93-104, 31 out. 2021. http://dx.doi.org/10.12775/tis.2021.007.
BRANCH, Sarah K.; AGRANAT, Israel. “New Drug” Designations for New Therapeutic Entities: new active substance, new chemical entity, new biological entity, new molecular entity. Journal Of Medicinal Chemistry, [S.L.], v. 57, n. 21, p. 8729-8765, 4 set. 2014. http://dx.doi.org/10.1021/jm402001w.
CASTILHO, Denis. Um vírus com DNA da globalização: o espectro da perversidade. Espaço e Economia, [S.L.], n. 17, p. 1-7, 7 abr. 2020. http://dx.doi.org/10.4000/espacoeconomia.10332.
CHAVEIRO, Eguimar Felício; GONÇALVES, Ricardo Junior de Assis Fernandes. As Margens das Margens das Margens: Saúde do Trabalhador em Tempos de Pandemia da Covid-19. Revista Terceiro Incluído, [S.L.], v. 10, n. 1, p. 227-239, 31 dez. 2020. http://dx.doi.org/10.5216/teri.v10i1.66150.
CITELINE. Pharma Intelligence. Pharma R&D: annual review 2022. Londres (Inglaterra): Pharma Intelligence, 2022. 55 p. Disponível em: https://pharmaintelligence.informa.com/. Acesso em: 23 jan. 2023.
DAMAS, Roberto Dumas. China x EUA: como a economia global e a geopolítica se comportarão no pós-pandemia. São Paulo (Brasil): Saint Paul, 2021. 222 p.
DCB - Daxue Consulting Beijing. China’s pharmaceutical industry will be the world’s largest in less than 10 years. Pequim, China. 2022. 4 p. Disponível em: https://daxueconsulting.com/pharmaceutical-industry-china. Acesso em: 14 fev. 2024.
DIMASI, Joseph A. et al. Innovation in the pharmaceutical industry: new estimates of R&D costs. Journal Of Health Economics, [S.L.], v. 47, p. 20-33, mai. 2016. http://dx.doi.org/10.1016/j.jhealeco.2016.01.012.
DOROCKI, Sławomir. Contemporary Trends in the Development of the Pharmaceutical Industry in the World. Studies of the Industrial Geography Commission of the Polish Geographical Society, [S.L.], v. 25, p. 108-131, 15 jan. 2014. http://dx.doi.org/10.24917/20801653.25.6.
EFPIA - The European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures. Belgica: EFPIA, 2022. 28 p. Disponível em: https://www.efpia.eu/. Acesso em: 6 fev. 2024.
FACHER, Lev. Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds. STAT. Boston, EUA. 2021. Disponível em: https://www.statnews.com/feature/prescription-politics/state-full-data-set/. Acesso em: 26 jan. 2024.
FAZAL, Tanisha M.. Health Diplomacy in Pandemical Times. International Organization, [S.L.], v. 74, n. 1, p. 78-97, 16 set. 2020. Cambridge University Press. http://dx.doi.org/10.1017/s0020818320000326.
FORBES. The Global 2000 ranking the world’s largest companies. Jersey City, NJ, EUA: 2023. Disponível em: https://www.forbes.com/lists/global2000/. Acesso em: 10 dez. 2023.
GAUTTAM, Priya et al. COVID-19 and Chinese Global Health Diplomacy: geopolitical opportunity for china’s hegemony?. Millennial Asia, [S.L.], v. 11, n. 3, p. 318-340, 12 out. 2020. http://dx.doi.org/10.1177/0976399620959771.
GCPPP - Global Commission for Post-Pandemic Policy. Covid-19 vaccine production, to July 31st, 2021. GCPPP. 2021. Disponível em: https://globalcommissionforpostpandemicpolicy.org/covid-19-vaccine-production-to-july-31st-2021/. Acesso em: 10 jan. 2024.
GIRÓN, Alicia. Geopolitics and Financial Profitability, the Big Pharmaceutical Corporations. Journal of Economic Issues, [S.L.], v. 56, n. 2, p. 562-569, 3 abr. 2022. http://dx.doi.org/10.1080/00213624.2022.2065853.
GLOBALDATA. Pharma Industry Mergers and Acquisitions Deals by Top Themes in 2022. Londres: (Inglaterra). GlobalData, 2023. 22 p. Disponível em: https://www.globaldata.com/store/report/pharma-industry-m-and-a-deals-by-theme-analysis/. Acesso em: 12 dez. 2023.
HAYES, Michael J.; PRASAD, Vinay. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings. Hastings Center Report, [S.L.], v. 48, n. 2, p. 10-13, mar. 2018. http://dx.doi.org/10.1002/hast.833.
HIGHAM, Scott; BERNSTEIN, Lenny. The Drug Industry’s Triumph over the DEA. The Washington Post. Washington, Estados Unidos. out. 2017. Disponível em: https://www.washingtonpost.com/graphics/2017/investigations/dea-drug-industry-congress/. Acesso em: 28 dez. 2023.
HORNSEY, Matthew J. et al. Donald Trump and vaccination: the effect of political identity, conspiracist ideation and presidential tweets on vaccine hesitancy. Journal of Experimental Social Psychology, [S.L.], v. 88, p. 103947, mai. 2020. http://dx.doi.org/10.1016/j.jesp.2019.103947.
IBEF - India Brand Equity Foundation. Indian Pharmaceutical Industry. New Delhi, India: Department of Commerce, Ministry of Commerce and Industry, Government of India., 2023. 34 p. Disponível em: https://www.ibef.org/industry/pharmaceutical-india. Acesso em: 9 dez. 2023.
INVEST INDIA - India's national investment facilitation agency. India: Pharmacy to the World. New Delhi, India: Strategic Investment Research Unit (SIRU), 2020. 25 p. Disponível em: https://www.investindia.gov.in/siru/india-pharmacy-world. Acesso em: 9 dez. 2023.
JAKOVLJEVIC, Mihajlo et al. Asian innovation in pharmaceutical and medical device industry - beyond tomorrow. Journal Of Medical Economics, [S.L.], v. 24, n. 1, p. 42-50, 16 nov. 2021. http://dx.doi.org/10.1080/13696998.2021.2013675.
KAMIIKE, Atsuko. The TRIPS Agreement and the Pharmaceutical Industry in India. Journal Of Interdisciplinary Economics, [S.L.], v. 32, n. 1, p. 95-113, 5 dez. 2019. http://dx.doi.org/10.1177/0260107919875573.
KAPCZYNSKI, Amy. The Political Economy of Market Power in Pharmaceuticals. Journal of Health Politics, Policy and Law, [S.L.], v. 48, n. 2, p. 215-239, 27 set. 2022. http://dx.doi.org/10.1215/03616878-10234184
KESSELHEIM, Aaron S. et al. Determinants of Market Exclusivity for Prescription Drugs in the United States. Jama Internal Medicine, [S.L.], v. 177, n. 11, p. 1658, 1 nov. 2017. http://dx.doi.org/10.1001/jamainternmed.2017.4329.
KNIGHT, Victoria et al. Pharma Campaign Cash Delivered to Key Lawmakers with Surgical Precision. KFF Health News. out. 2021. Disponível em: https://kffhealthnews.org/news/article/pharma-campaign-cash-delivered-to-key-lawmakers-with-surgical-precision/. Acesso em: 26 jan. 2024.
LAKDAWALLA, Darius N.. Economics of the Pharmaceutical Industry. Journal of Economic Literature, [S.L.], v. 56, n. 2, p. 397-449, 1 jun. 2018. http://dx.doi.org/10.1257/jel.20161327.
LEE, Seow Ting. Vaccine diplomacy: nation branding and china’s covid-19 soft power play. Place Branding and Public Diplomacy, [S.L.], v. 19, n. 1, p. 64-78, 6 jul. 2021. http://dx.doi.org/10.1057/s41254-021-00224-4.
LIU, Liangtao et al. China’s Vaccine Diplomacy and Its Implications for Global Health Governance. Healthcare, [S.L.], v. 10, n. 7, p. 1276, 10 jul. 2022. http://dx.doi.org/10.3390/healthcare10071276.
LURIE, Peter et al. Financial Conflict of Interest Disclosure and Voting Patterns at Food and Drug Administration Drug Advisory Committee Meetings. JAMA, [S.L.], v. 295, n. 16, p. 1921, 26 abr. 2006. http://dx.doi.org/10.1001/jama.295.16.1921
MCCARTHY, Tom. The race for a vaccine: how Trump's 'America First' approach hinders the global search. The Guardian. Londres (Inglaterra), mai. 2020. Disponível em: https://www.theguardian.com/world/2020/may/12/the-race-for-a-vaccine-how-trumps-america-first-approach-slows-the-global-search. Acesso em: 16 mar. 2024.
MELLO-THÉRY, Neli Ap. de; THÉRY, Hervé. A geopolítica do COVID-19. Espaço e Economia, [S.L.], n. 17, p. 1-9, 7 abr. 2020. OpenEdition. http://dx.doi.org/10.4000/espacoeconomia.11224.
MOHIUDDIN, Muhammad et al. Relocating high-tech industries to emerging markets: case of pharmaceutical industry outsourcing to India. Transnational Corporations Review, [S.L.], v. 9, n. 3, p. 201-217, 3 jul. 2017. http://dx.doi.org/10.1080/19186444.2017.1370808.
MOL, Rajani et al. India’s Health Diplomacy as a Soft Power Tool towards Africa: humanitarian and geopolitical analysis. Journal of Asian and African Studies, [S.L.], v. 57, n. 6, p. 1109-1125, 17 set. 2021. http://dx.doi.org/10.1177/00219096211039539.
NEJSTGAARD, Camilla H et al. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ, [S.L.], p. 1-12, 9 dez. 2020. http://dx.doi.org/10.1136/bmj.m4234.
NISHINO, Anna et al. The great medicines migration: how china took control of key global pharmaceutical supplies. Nikkei Asia. Tokyo, Japão, p. 1. abr. 2022. Disponível em: https://asia.nikkei.com/static/vdata/infographics/chinavaccine-3/. Acesso em: 12 dez. 2023.
OECD. Health at a Glance 2021: OECD indicators. Paris, França: OECD Publishing, 2021. 274 p. https://doi.org/10.1787/ae3016b9-en.
OPENSECRETS - The nation's premier research group tracking money in U.S. politics. 2023. Washington, Estados Unidos. Disponível em: https://www.opensecrets.org/. Acesso em: 24 abr. 2023.
PAREXEL - International Corporation. The Chinese Pharmaceutical Market: size, r&d, regulations, market access and innovations. Durham, Estados Unidos: Parexel, 2022. 37 p. Disponível em: https://healthadvances.com/whitepaper/health-advances-asia-pacific-pharma.pdf. Acesso em: 11 jun. 2023.
PHAM-KANTER, Genevieve. Revisiting Financial Conflicts of Interest in FDA Advisory Committees. Milbank Quarterly, [S.L.], v. 92, n. 3, p. 446-470, set. 2014. http://dx.doi.org/10.1111/1468-0009.12073.
PINA, Ana Sofia et al. An Historical Overview of Drug Discovery. Ligand-Macromolecular Interactions in Drug Discovery, [S.L.], p. 3-12, 3 out. 2009. http://dx.doi.org/10.1007/978-1-60761-244-5_1.
SALAMON, Lester M.; SIEGFRIED, John J.. Economic Power and Political Influence: the impact of industry structure on public policy. American Political Science Review, [S.L.], v. 71, n. 3, p. 1026-1043, set. 1977. http://dx.doi.org/10.2307/1960105.
SENHORAS, Elói Martins. O Campo de poder das vacinais na Pandemia da Covid-19. Zenodo, [S.L.], v. 18, n. 6, p. 110-121, 22 jun. 2021. http://dx.doi.org/10.5281/ZENODO.5009525.
SHI - The Science History Institute. Alexander Fleming. 2023. Education: Scientific Biographies. Disponível em: https://sciencehistory.org/education/scientific-biographies/alexander-fleming/. Acesso em: 18 dez. 2023.
SOUZA, José Gilberto; GUIMARÃES, Raul. Pandemia de Covid-19: uma análise geopolítica. Saúde e Sociedade, [S.L.], v. 30, n. 1, p. 1-19, 2021. (SciELO). http://dx.doi.org/10.1590/s0104-12902021200649.
STATISTA - Insights and facts across 170 industries and 150 countries. Pharmaceutical market: worldwide revenue 2001-2022. Hamburgo, Alemanha. 2023a. Disponível em: https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/. Acesso em: 30 nov. 2023.
STATISTA - Insights and facts across 170 industries and 150 countries. Key Players: Pharmaceuticals - Worldwide. Hamburgo, Alemanha. 2023b. Disponível em: https://www.statista.com/outlook/hmo/pharmaceuticals/worldwide#key-players. Acesso em: 14 nov. 2023.
STATISTA - Insights and facts across 170 industries and 150 countries. Pharmaceutical industry in China: statistics & facts. Hamburgo, Alemanha. 2022c. Disponível em: https://www.statista.com/topics/5001/pharmaceutical-industry-in-china/#topicOverview. Acesso em: 15 dez. 2023.
STATISTA - Insights and facts across 170 industries and 150 countries. Top 20 pharmaceutical companies worldwide based on prescription drug market share in 2019 and 2026. Hamburgo, Alemanha. 2022a. Disponível em: https://www.statista.com/outlook/hmo/pharmaceuticals/worldwide#key-players. Acesso em: 14 dez. 2023.
STATISTA - Insights and facts across 170 industries and 150 countries. Total global spending on pharmaceutical research and development from 2014 to 2028. Hamburgo, Alemanha. 2022b. Disponível em: https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/. Acesso em: 16 dez. 2023.
TANNOURY, Maya; ATTIEH, Zouhair. The Influence of Emerging Markets on the Pharmaceutical Industry. Current Therapeutic Research, [S.L.], v. 86, p. 19 22, 2017. http://dx.doi.org/10.1016/j.curtheres.2017.04.005
TORBATI, Yeganeh; O'CONNELL, Jonathan. Pharmaceutical industry likely to shatter its lobbying record as it works to shape Democrats’ spending bill. The Washington Post. Washington, Estados Unidos. nov. 2021. Disponível em: https://www.washingtonpost.com/business/2021/11/05/pharmaceutical-industry-drug-price-lobbying/. Acesso em: 26 nov. 2023.
WB - World Bank. Data Bank: Gross Domestic Product (GDP). 2023. Disponível em: https://databank.worldbank.org/. Acesso em: 20 nov. 2023.
WOUTERS, Olivier J. Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018. JAMA Internal Medicine, v. 180, n. 5, p. 688, mai. 2020. https://doi.org/10.1001/jamainternmed.2020.0146.
XU, Jian et al. Government subsidies, R&D investment and innovation performance: analysis from pharmaceutical sector in China. Technology Analysis & Strategic Management, v. 33, n. 5, p. 535-553, 9 out. 2020. http://dx.doi.org/10.1080/09537325.2020.1830055.
YU, Peter K. China’s Innovative Turn and the Changing Pharmaceutical Landscape. University of the Pacific Law Review, Stockton, CA, US, v. 3, n. 51, p. 593-620, fev. 2019. Disponível em: https://heinonline.org/HOL/LandingPage?handle=hein.journals/mcglr51&div=38. Acesso em: 12 jun. 2023.
WILKS, Stephen. The Political Power of the Business Corporation. Cheltenham (Reino Unido): Edward Elgar Publishing, 2013. 336 p.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 1969 Da Revista Geopauta e do(s) Autor(es)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Dos Direitos Autorais
Os autores mantêm os direitos autorais de forma irrestrita e concedem à Geopauta a primeira publicação com o trabalho simultaneamente licenciado em CC BY.que permite que outros compartilhem com reconhecimento da autoria de cada autor na publicação inicial nesta revista.
Propriedade Intelectual e Termos de uso
Geopauta adota a política de Acesso Livre em Conformidade com o Acesso Aberto- OAC recomendado pelo DOAJ e em conformidade com os Critérios SciELO, sob uma licença Creative Commons CC By Attribution 4.0 International License, permitindo acesso gratuito imediato ao trabalho e permitindo que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreie-os para indexação, passe-os como dados para software ou use-os para qualquer outra finalidade legal.
Geopauta atribui a licença CC BY. onde é permitido sem restrições:
Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial. desde que lhe atribuam o devido crédito pela criação original.
Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial desde que lhe atribuam o devido crédito pela criação original.
